Chemical
Rossari Biotech's income doubles in Q4FY22
Net profit rose by 7.38% to reach Rs.24.08 crores in Q4FY22 versus Rs.22.42 crores for the period ended March 31, 2021
-
By ICN Bureau | May 20, 2022
Rossari Biotech Limited has reported consolidated financial results for the period ended March 31, 2022. The company's total income jumped by 100% to reach Rs. 440.90 crores in Q4FY22 as against Rs.220.26 crores in the same quarter last year.
Net profit rose by 7.38% to reach Rs.24.08 crores in Q4FY22 versus Rs.22.42 crores for the period ended March 31, 2021.
The company has reported EPS growth of 1.40% at Rs. 4.35 in Q4 as compared to Rs.4.29 for the period ended March 31, 2021.
The company's board has recommended final dividend of 25% (i.e. Re. 0.50 /- per share) on equity shares of the face value of Rs. 2/- each for FY22, subject to approval of the shareholders at the forthcoming AGM.
For the full year, the company's total income grew by 108% to reach Rs.1494.97 crores in FY22 as compared to Rs.718.04 crores in FY21.
Company's net profit rose by 21.76% and stood at Rs.97.674 crores in FY22 as against Rs.80.22 crores in FY21.
The company has reported EPS of Rs.17.70 in FY22 as compared to Rs.15.47 last year.
Register Now to Attend Chem Connect 2025 on August 21th 2025, Novotel Mumbai International Airport
